KB
GH icon

Kimelman & Baird’s Guardant Health GH Stock Holding History

Kimelman & Baird’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$176K Hold
1,900
– – 0.01% 116
2025
Q4 		$194K Hold
1,900
– – 0.01% 115
2025
Q3 		$119K Hold
1,900
– – 0.01% 138
2025
Q2 		$98.9K Hold
1,900
– – 0.01% 147
2025
Q1 		$80.9K Hold
1,900
– – 0.01% 158
2024
Q4 		$58K Buy
+1,900
New +$53.5K ﹤0.01% 173

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kimelman & Baird's GH Position: Q1 2026 in Review

Kimelman & Baird held its Guardant Health (GH) position steady in Q1 2026 at 1,900 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #116.

Kimelman & Baird first reported a position in GH in Q4 2024 and has held it in 6 quarters since. The position peaked at $194K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Kimelman & Baird held 1,900 shares of Guardant Health worth $176K as of Q1 2026.
  • Kimelman & Baird left its Guardant Health share count unchanged in Q1 2026.
  • Guardant Health made up 0.01% of Kimelman & Baird's portfolio in Q1 2026, its #116 holding.
  • Kimelman & Baird first reported a position in Guardant Health in Q4 2024 and has held it in 6 quarters since.
  • Kimelman & Baird's Guardant Health position peaked at $194K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.